FRANCISCI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 12.215
AS - Asia 8.999
EU - Europa 8.737
SA - Sud America 1.770
AF - Africa 249
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 14
Totale 32.000
Nazione #
US - Stati Uniti d'America 11.910
SG - Singapore 4.526
IE - Irlanda 1.490
IT - Italia 1.443
BR - Brasile 1.365
RU - Federazione Russa 1.297
CN - Cina 1.126
HK - Hong Kong 1.120
UA - Ucraina 1.057
SE - Svezia 971
VN - Vietnam 742
DE - Germania 575
FR - Francia 573
FI - Finlandia 386
GB - Regno Unito 311
KR - Corea 288
BD - Bangladesh 262
IN - India 193
CA - Canada 142
AR - Argentina 140
AT - Austria 131
TR - Turchia 123
PL - Polonia 96
MX - Messico 84
IQ - Iraq 83
JP - Giappone 73
NL - Olanda 71
UZ - Uzbekistan 65
ZA - Sudafrica 65
ID - Indonesia 64
ES - Italia 62
CO - Colombia 57
VE - Venezuela 56
EC - Ecuador 55
PK - Pakistan 54
CH - Svizzera 51
BE - Belgio 50
SA - Arabia Saudita 44
MA - Marocco 38
EE - Estonia 36
PH - Filippine 34
CL - Cile 26
PY - Paraguay 26
MY - Malesia 25
CZ - Repubblica Ceca 24
EG - Egitto 24
KE - Kenya 24
AE - Emirati Arabi Uniti 23
LT - Lituania 20
JO - Giordania 19
BO - Bolivia 17
GR - Grecia 17
DZ - Algeria 15
LB - Libano 15
RO - Romania 15
IL - Israele 14
PE - Perù 13
TN - Tunisia 13
AU - Australia 12
AZ - Azerbaigian 12
ET - Etiopia 12
EU - Europa 12
NP - Nepal 12
OM - Oman 12
CR - Costa Rica 11
JM - Giamaica 11
PA - Panama 11
UY - Uruguay 11
IR - Iran 10
HN - Honduras 9
NG - Nigeria 8
NI - Nicaragua 8
DO - Repubblica Dominicana 7
KZ - Kazakistan 7
SN - Senegal 7
TW - Taiwan 7
AL - Albania 6
AO - Angola 6
BG - Bulgaria 6
CI - Costa d'Avorio 6
PT - Portogallo 6
SY - Repubblica araba siriana 6
BY - Bielorussia 5
GT - Guatemala 5
HR - Croazia 5
PS - Palestinian Territory 5
QA - Qatar 5
KW - Kuwait 4
NO - Norvegia 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BH - Bahrain 3
DK - Danimarca 3
GA - Gabon 3
LV - Lettonia 3
LY - Libia 3
MD - Moldavia 3
Totale 31.924
Città #
Singapore 3.211
Dublin 1.485
Chandler 1.305
San Jose 1.282
Hong Kong 1.114
Ashburn 760
San Mateo 755
Boardman 564
Santa Clara 505
Jacksonville 496
Moscow 463
Perugia 432
Altamura 415
Medford 381
Princeton 381
Lauterbourg 354
Dong Ket 321
Lawrence 304
Seoul 286
Wilmington 279
Ann Arbor 254
Andover 231
Los Angeles 204
Beijing 192
New York 185
The Dalles 183
Ho Chi Minh City 161
Columbus 156
Des Moines 143
Munich 142
Piscataway 128
São Paulo 125
Saint Petersburg 97
Dearborn 93
Hanoi 87
Helsinki 77
Norwalk 77
Redmond 77
Woodbridge 74
Nuremberg 73
Falls Church 70
Frankfurt am Main 69
Tokyo 67
Rome 59
Houston 58
San Paolo di Civitate 58
Shanghai 56
Dallas 55
Orem 54
Vienna 50
Montreal 48
Brussels 47
Warsaw 47
Chicago 46
Izmir 46
Turku 46
Rio de Janeiro 43
London 38
Johannesburg 37
Tashkent 37
Brooklyn 36
Chennai 36
Amsterdam 34
San Francisco 34
Denver 32
Toronto 32
Baghdad 31
Milan 30
Hefei 29
Phoenix 29
Boston 28
Mexico City 27
Philadelphia 27
Poplar 27
Redwood City 26
Stockholm 26
Belo Horizonte 25
Den Haag 25
Manchester 25
Brasília 24
Ankara 23
Atlanta 23
Medellín 23
Dhaka 22
Florence 22
Buffalo 21
Curitiba 21
Falkenstein 21
Bologna 19
Porto Alegre 19
Haiphong 18
Nairobi 18
Campinas 17
Mumbai 17
Naples 17
Ottawa 17
Riyadh 17
Amman 16
Caracas 16
Da Nang 16
Totale 19.849
Nome #
NUtraceutical TReatment for hYpercholesterolemia in HIV-infected patients: The NU-TRY(HIV) randomized cross-over trial 168
Accelerate Pheno™ system in sepsis by Gram-negative pathogens: four months of hospital experience 167
Diagnosis of central nervous system herpes virus infections by a single multiplex PCR. 11th European Congress of Clinical Microbiology and Infectious Diseases 158
Concentrazioni ossee e plasmatiche di moxifloxacina in pazienti operati di protesi di ginocchio 156
A case of Propionibacterium acnes meningitis: additional evidence for anaerobes in neurosurgical infections 150
Amfotericina B in complessi lipidici nel trattamento della Leishmaniosi viscerale in un paziente immunodepresso 150
Anti-HIV Protease Inhibitors Interact With NSAIDs and Exacerbate Small Intestine Enteropathy Induced by NSAIDs 147
SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione 146
The bile acid receptor GPBAR1 regulates the M1/M2 phenotype of intestinal macrophages and activation of gpbar1 rescues mice from murine colitis 145
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection 143
A case of severe cdfepime-related neutropenia in a 15-year-old patient 142
Anal Cancer Screening for Diagnosis and Treatment of Anal Squamous Intraepithelial Lesions in HIV-positive MSM patients 137
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 135
Effect of aspirin treatment on abacavir-associated platelet hyperreactivity in HIV-infected patients 134
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 133
Acute fatal necrotizing hemorrhagic encephalitis caused by Epstein-Barr virus in a young adult immunocompetent man 132
Esperienza con Efavirenz nei pazienti con infezione da HIV seguiti presso la Clinica di Malattie Infettive di Perugia 131
A randomized trial comparing the introduction of ritonavir on indinavir in 1251 nucleoside-experienced patients with advanced HIV infection 129
Bone and serum concentrations of moxifloxacin in patients undergoing total knee arthroplasty 128
Acute appendicitis due to Cytomegalovirus in an apparently immunocompetent patient: a case report 127
Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: a prospective multicentre study 124
Acute cytomegalovirus meningomyelitis in an immunocompetent patient. 124
Impact of tenofovir versus abacavir on HIV-related endothelial dysfunction. 124
Mielite da Toxoplasma gondii in un paziente con AIDS 123
Epidemiological, clinical and therapeutical aspects of HIV/HCV coinfection in a series of HIV seropositive Umbrian patients. 123
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 123
Leflunomide protects against dyslipidemia development induced by ritonavir in mice 122
Impact of Antimicrobial Stewardship Interventions on Appropriateness of Surgical Antibiotic Prophylaxis: How to Improve 121
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 121
HIV type 1 infection, and not short-term HAART, indice endothelial dysfunction. 120
ISS-NIA ITALIAN COHORT: NEW ANTI-HIV INHIBITORS IN PATIENTS EXPERIENCED TO IP, NRTI, NNRTI 120
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature 120
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected 120
Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59 adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy. 117
Nocardiosi cerebrale primaria in un paziente immunocompetente 116
Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2 115
A case of rhombencephalitis caused by Listeria monocytogenes successfully treated with linezolid 115
A nutraceutical combination targeting dyslipidemia and subclinical inflammation in HIV patients on stable antiretroviral therapy 114
Partial achievement of the 90-90-90 UNAIDS target in a cohort of HIV infected patients from Central Italy 114
Prima indagine sieroepidemiologica sulla circolazione del virus Toscana in Umbria. Atti congresso di malattie Infettive 113
In vivo platelet activation and platelet hyperreactivity in abacavir-treated HIV-infected patients. 113
L'infezione da Clostridium Difficile in pazienti ospedalizzati: uno studio retrospettivo. XXIX Congresso AMCLI 2000, 112
Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004. 112
Daily bathing with 4% chlorhexidine gluconate in intensive care settings: a randomized controlled trial 112
Alterazioni in HCMV end-organ disease in the course of highly active antiretroviral therapy (HAART). 112
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light 112
ANALISI DELLA FUNZIONALITÀ RENALE IN PAZIENTI CON INFEZIONE DA HIV NAIVE TRATTATI CON TENOFOVIR. STUDIO CASO-CONTROLLO. 111
Effects of antiretroviral therapy on lipid and immunovirological profile: Focus on proprotein convertase subtilisin/kexin 9 111
A first update on mapping the human genetic architecture of COVID-19 110
Trattamento dell'epatite cronica C con IFN-2b e ribavirina in pazienti non responder o relapser a solo IFN-: dati preliminari sulla nostra esperienza. 110
Fatal Haemolytic Uraemic Syndrome in an AIDS patient with disseminated Adenovirus and Cytomegalovirus co-infection. 110
In vitro antibacterial activity of ceftazidime/avibactam in combination against planktonic and biofilm carbapenemase-producing Klebsiella pneumoniae isolated from blood 110
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 110
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease. 109
Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty 109
Epidemiologia, clinica e terapia della coinfezione HIV-HCV nell'esperienza umbra. 108
Beneficial effect of recombinant human granulocyte colony-stimulating factor on fungicidal activity of polymorphonuclear leukocytes from patients with AIDS 108
Acute infection with parvovirus B19 manifesting as brain stem encephalitis. 108
Mapping the human genetic architecture of COVID-19 108
Effect of High-Titer Convalescent Plasma on Progression to Severe Respiratory Failure or Death in Hospitalized Patients With COVID-19 Pneumonia A Randomized Clinical Trial 108
Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors. 107
Malattie Infettive trasmesse da Zecca in Umbria: indagine epidemiologica 106
Risk factors for acute parenterally transmitted viral hepatitis: a 20-year study. 106
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 106
Target di autoimmunità endocrina in corso di terapia con IFN-alfa in pazienti con epatite cronica da HCV. 30°congr.naz. SISMIP, Ferrara 6-9 ottobre 1999 105
Modificazioni epidemiologiche delle epatiti virali acute in Umbria; 30 anni di osservazione. Congresso Soc. It. Mal. Inf. 105
Encefalite emorragica e infezione disseminata da Epstein barr virus: descrizione di un caso clinico con outcome fatale. 105
Tuberculosis After Gastrectomy, Plasmatic Concentration of Antitubercular Drugs 105
Monocyte dysfunction in patients with acquired immunodeficiency syndrome (AIDS) versus Cryptococcus neoformans 104
Combined ganciclovir and foscarnet therapy of recurrent cytomegalovirus and aggressive retinitis in AIDS 104
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 104
Procalcitonin, white blood cell count and C-reactive protein as predictors of S. aureus infection and mortality in infective endocarditis 104
A proposal for a comprehensive approach to infections across the surgical pathway 104
Long term treatment of a variant form of autoimmune chronic active hepatitis with cyclosporine: a case report. 104
Tipranavir exhibits different effects on opportunistic pathogenic fungi. 103
Biochemical markers of bone turnover and calcium dietary intake evaluation in HIV-infected patients 103
Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality 103
Tolerability of different postexposure prophylaxis regimens in occupational and non occupational exposures to HIV: the italian registry 102
Patologie neurologiche AIDS-defining in era HAART e Pre-HAART: nuovi scenari 102
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations. 101
Predictive risk factors for worse outcomes in COVID-19 patients with different clinical features at baseline 101
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study 101
Low brachial artery flow-mediated dilation predicts worse prognosis in hospitalized patients with covid-19 101
Benefits of a rapid HIV test for evaluation of the source patient after occupational exposure of healthcare workers. 100
Metodo rapido di estrazione dell'RNA da C. neoformans. 100
Hepatitis C virus genotypes in the liver and serum of patients with chronic hepatitis C 100
Programmed granulocyte neutrophil death in patients at different stages of HIV infection 99
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 99
Burden of Disease in PWH Harboring a Multidrug-Resistant Virus: Data from the PRESTIGIO Registry 99
CD4/CD8 ratio in pregnant women with HIV and its association with pregnancy outcome: data from a national study in Italy 99
Malattie da virus a DNA- Citomegalovirosi 98
Thyroid function tests in acute viral hepatitis:relative reduction in serum thyroxine levelsdue to T4-TBG binding inhibitors in patients with severe liver cell necrosis 98
Maraviroc Intensification Modulates Atherosclerotic Progression in HIV-Suppressed Patients at High Cardiovascular Risk. A Randomized, Crossover Pilot Study 98
Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria 97
La terapia HAART nell'esperienza della clinica di Malattie Infettive di Perugia 97
Correlation of preS antigens and clinical status during chronic hepatitis B virus infection. 97
A Novel Source of Intestinal Damage: The HIV Protease Inhibitor Ritonavir Worsens Damage Caused by COX Inhibitors 96
Genetic Ablation and Pharmacological Blockade of CCR5 by the anti-HIV Small Molecule Inhibitor Maraviroc Inhibits Leukocyte Trafficking and Protects Against Mucosal Inflammation in Murine Models Colitis 96
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 96
Delivery in asymptomatic Italian woman with SARS-CoV-2 infection 96
Totale 11.501
Categoria #
all - tutte 155.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.100


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.052 98 531 84 184 109 55 48 912 70 106 387 468
2022/20235.045 429 995 76 384 365 495 25 202 1.839 6 171 58
2023/20241.833 106 208 91 41 16 16 417 32 212 74 341 279
2024/20255.565 49 546 130 166 698 228 332 365 1.336 370 735 610
2025/202612.044 836 757 773 1.582 1.462 973 2.239 687 1.301 857 373 204
2026/2027245 245 0 0 0 0 0 0 0 0 0 0 0
Totale 33.071